Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-21

Clinical Trial Update: Treatment of Tendinosis Using the TenJet Hydroresection System

View source ↗

Summary

A clinical trial evaluating the TenJet Hydroresection System for tendinopathy and tendinosis is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TenJet Hydroresection System

Snippet

Sponsor: Rothman Institute Orthopaedics | Conditions: Tendinopathy, Tendinosis | Status: ENROLLING_BY_INVITATION